Janux Therapeutics, Inc. — insider transactions
3 transactions on record · JANX · CIK 1817713
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$29.5K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$29.5K
2026-07-08
Director share, 12m
100.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$29.5K
purchases minus sales
Total on record
3
Transactions
3 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 2026-07-31 | 0 | Campbell David Alan | Director, President and CEO | Gift | 123,840 | $0.00 | — | filing |
| 2026-07-10 | 2026-07-08 | 2 | Campbell David Alan | Director, President and CEO | Exercise of derivative | 7,000 | $0.00 | — | filing |
| 2026-07-10 | 2026-07-08 | 2 | Campbell David Alan | Director, President and CEO | Exercise of derivative | 7,000 | $4.21 | $29.5K | filing |